1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 101-110 of 316 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, mutlicentre, randomised phase 3 studyBuikhuisen, W.; Burgers, J.; Vincent, A.; Korse, C.; van Klaveren, R.; Schramel, F.; Pavlakis, N.; Nowak, A.; Custers, F.; Schouwink, J.; Gans, S.; Groen, H.; Strankinga, W.; Baas, P.
2013Low wear of a second-generation highly crosslinked polyethylene liner: a 5-year radiostereometric analysis studyCallary, S.; Field, J.; Campbell, D.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2014Preoperative factors predicting clinical outcome following laparoscopic fundoplicationStaehelin, A.; Zingg, U.; Devitt, P.; Esterman, A.; Smith, L.; Jamieson, G.; Watson, D.
2013Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trialVermorken, J.; Stohlmacher-Williams, J.; Davidenko, I.; Licitra, L.; Winquist, E.; Villanueva, C.; Foa, P.; Rottey, S.; SkladowskI, K.; Tahara, M.; Pai, V.; Faivre, S.; Blajman, C.; Forastiere, A.; Stein, B.; Oliner, K.; Pan, Z.; Bach, B.
2013Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapyAngelini, S.; Soverini, S.; Ravegnini, G.; Barnett, M.; Turrini, E.; Thornquist, M.; Pane, F.; Hughes, T.; White, D.; Radich, J.; Kim, D.; Saglio, G.; Cilloni, D.; Iacobucci, I.; Perini, G.; Woodman, R.; Cantelli-Forti, G.; Baccarani, M.; Hrelia, P.; Martinelli, G.
2013Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation a randomized clinical trialAbed, H.; Wittert, G.; Leong, D.; Shirazi, M.; Bahrami, B.; Middeldorp, M.; Lorimer, M.; Lau, D.; Antic, N.; Brooks, A.; Abhayaratna, W.; Kalman, J.; Sanders, P.
2013Pharmacovigilance in hospice/palliative care: net effect of haloperidol for deliriumCrawford, G.; Agar, M.; Quinn, S.; Phillips, J.; Litster, C.; Michael, N.; Doogue, M.; Rowett, D.; Currow, D.
2014Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingPishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.
2013Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: Late outcomes from two randomized trialsSie, C.; Bright, T.; Schoeman, M.; Game, P.; Tam, W.; Devitt, P.; Watson, D.

Discover